Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.15 USD | +8.32% |
|
-.--% | +17.44% |
06-20 | Basilea Pharmaceutica to Sell Brain Cancer Drug Candidate to US-based Nonprofit | MT |
06-20 | Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation | DJ |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BASILEA PHARMACEUTICA AG | Other Biotechnology & Medical Research | +8.32% | -.--% | +17.44% | -3.70% | +31.16% | 534M | - | - | - |
- Stock Market
- Equities
- BSLN Stock
- BPMUF Stock
- Charts Basilea Pharmaceutica AG
- Relative Strength Chart